BIOGEN publishes study results for high-dose nusinersen in Nature Medicine
Go back to BIOGEN publishes study results for high-dose nusinersen in Nature Medicine| BIOGEN IDEC Inc. (NASDAQ: BIIB) | Delayed: 202.19 +1.57 (0.78%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $200.62 | 52 Week High | $333.65 | |||
| Open | $202.24 | 52 Week Low | $223.02 | |||
| Day High | $203.30 | P/E | 25.89 | |||
| Day Low | $200.04 | EPS | $7.81 | |||
| Volume | 596,267 | |||||
| (NASDAQ: IONS) | Delayed: 56.55 +0.68 (1.22%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $55.87 | 52 Week High | $62.68 | |||
| Open | $56.32 | 52 Week Low | $19.59 | |||
| Day High | $57.36 | P/E | N/A | |||
| Day Low | $56.19 | EPS | $0.00 | |||
| Volume | 3,094,729 | |||||
